Evidence map›Paper›PMID 15251044›Full record

ArticleBMC biotechnology2004

Two-fold differences are the detection limit for determining transgene copy numbers in plants by real-time PCR.

Ben Bubner, Klaus Gase, Ian T Baldwin

Abstract read
In one paragraph

Article in BMC biotechnology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed.

  1. Innate immunity · 2020
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. microRNA390 modulatesPlant direct · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The complete chloroplast genome and phylogenetic analysis ofMitochondrial DNA. Part B, Resources · 2021
    Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ben BubnerDepartment of Molecular Ecology, Max-Planck-Institute for Chemical Ecology, Hans-Knöll-Str, 8, 07745 Jena, Germany. bubner@ice.mpg.de
Klaus Gase
Ian T Baldwin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfter transformation, plants that are homozygous and contain one copy of the transgene are typically selected for further study. If real-time PCR is to be used to determine copy number and zygosity, it must be able to distinguish hemizygous from homozygous and one-copy from two-copy plants. That is, it must be able to detect two-fold differences.

resultsWhen transgenic Nicotiana attenuata plants which had been previously determined by Southern analysis to contain one or two copies of the transgene, were analyzed by real-time PCR (2-delta delta Ct method), the method failed to confirm the results from the Southern analysis. In a second data set we analyzed offspring of a hemizygous one-copy plant, which were expected to segregate into three groups of offspring in a 1:2:1 ratio: no transgene, hemizygous, homozygous. Because it was not possible to distinguish homozygous from hemizygous plants with real-time PCR, we could not verify this segregation ratio.

conclusionsDetection of two-fold differences by real-time PCR is essential if this procedure is to be used for the characterization of transgenic plants. However, given the high variability between replicates, a detection of two-fold differences is in many cases not possible; in such cases Southern analysis is the more reliable procedure.

Indexed as

Computer SystemsGene DosageDNA, ComplementaryDNA, PlantDNA ProbesGene AmplificationGenetic VariationGenetic VectorsHeterozygotePlantsPlants, Genetically ModifiedPolymerase Chain ReactionTransgenesDNA, ComplementaryDNA, PlantDNA Probes

Identifiers

PMID15251044
PMCPMC493272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.